一级婬片试看120分钟,安徽少妇BBBB搡BBBB,波多野结衣一级片

香蕉91成人一区二区三区飘花,91精品人妻一区二区三区蜜桃,四川少妇BBw搡BBBB槡BBBB,国产成人91一区二区三区APP

<tr id="cc0cc"></tr>

<nav id="cc0cc"></nav><small id="cc0cc"></small>

<sup id="cc0cc"></sup>

CN

CN EN

Latest News

Latest News Media Downloads Video Center

Kexing Biopharm's clinical trial application accepted for human interferon α1b inhalation solution
2022-08-19

2022-08-19

On the evening of August 18, 2022, Kexing Biopharm...
Kexing Biopharm's clinical trial application accepted for another dosage form of human interferon α2b
2022-08-15

2022-08-15

On the evening of August 14, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had recently received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Human Interferon α2b Spray" was accepted.
Kexing Biopharm's clinical trial application accepted for "Pegylated Human Granulocyte Colony-stimulating Factor Injection"
2022-08-02

2022-08-02

On the evening of August 1, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had just received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Pegylated Human Granulocyte Colony-stimulating Factor Injection" was accepted.
Kexing Biopharm's conference for reviewing operation and management in first half of 2022and planning key tasks for the second half-year held successfully
2022-08-01

2022-08-01

In the face of the complicated political and economic environment in China and overseas as well as the tough situation in the pharmaceutical industry, Kexing Biopharm proposed the working policy themed as "intensely licensing in new products, firmly promoting R&D and innovation, and proactively creating business in new industries" at the beginning of the year, and continuously followed and implemented the policy in the first half-year.
Phase I clinical trial kick-off meeting of Kexing Biopharm's COVID-19 oral drug SHEN26 Capsule held successfully
2022-07-22

2022-07-22

On July 20, 2022, the phase I clinical trial kick-off meeting of SHEN26 Capsule, a small-molecule oral drug against COVID-19 jointly developed by Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kexing Biopharm (688136.SH), and Shenzhen Antiv Pharma Co., Ltd., was successfully held in the Second Affiliated Hospital of Anhui Medical University, indicating the official start of the clinical study for the project.

1 2 3 4 5

Support Hotline

0755-26546500
Online Consultation
QR Code

Scan Code Consultation

亚洲精晶无码成人精品AV | 水元惠梨香AV一区二区 | 搡老熟女大熟了88AV一区二区 | 精品中文字幕在线观看 | 日本中文字幕在线 | 蜜桃一区二区在线视频 | 全免费A级毛片免费视频播放 | 嫩草 www天堂资源在线观看 | 欧美毛片无码又大又粗蜜桃 | 农村寡妇偷人高潮完整版 | 无码人妻一区二区三区线花季传件 | 国产又粗又大又黄又爽 | 国产成人三级在线观看 | 麻豆激情一级A片亲族伦小说 | 国产第一页精品先锋影音视频 | 黄色成人网站在线浏览 | 韩国无码成人片在线观看 | 东北专干老熟女300部 | 美女高潮久久久久久久 | 农村胖妇女久久久精品 | 国产又爽又黄免费视频两年半 | 丝袜秘书一区二区三区四区 | 农村嫖妓一区二区三区 | 18黄色视频在线观看 | 波多野结衣在线视频3区4区 | 特级西西444WWW大精品视频 | 无码秘人妻一区二区三 | 久久久久久无码午夜精品直播 | 欧美黄色成人视频 | 高級中出人妻内射破解 | 在线视频福利你懂的 | 日韩AV免费在线观看网站 | 亚洲秘无码一区二区三区 93人妻人人揉人人躁人人 | 91人妻互换一区二区三区 | 成人网站黄色在线观看 | 不要,不要黄色成人视频免费观看 | 国产精品成人AV | 在线亚洲AV无码秘蜜桃医院 | 少女视频哔哩哔哩免费观看在线 | 美女mm131麻豆視頻 | 日本高清不卡在线播放 |

<tfoot id="ccccc"><dd id="ccccc"></dd></tfoot>

<nav id="ccccc"></nav>

<tr id="ccccc"></tr><tr id="ccccc"></tr>

<noscript id="ccccc"><dd id="ccccc"></dd></noscript>